Publikasi Scopus Covid-19 Per 14 Agustus 2024 (559 artikel)

Karina K.; Christoffel L.M.; Novariani R.; Rosadi I.; Rosliana I.; Rosidah S.; Sobariah S.; Fatkhurohman N.; Puspitaningrum N.; Hertati Y.; Afini I.; Ernanda D.; Widyastuti T.; Sulaeha A.D.; Zakiyah A.; Aini N.; Andrew H.
Karina, Karina (57212146678); Christoffel, Louis Martin (57226284594); Novariani, Rita (57226291299); Rosadi, Imam (57204720098); Rosliana, Iis (57186671400); Rosidah, Siti (57226293430); Sobariah, Siti (57203547382); Fatkhurohman, Novy (57226292972); Puspitaningrum, Nurlaela (57226271886); Hertati, Yuli (57226271456); Afini, Irsyah (57211068324); Ernanda, Difky (57226273639); Widyastuti, Tias (57211074403); Sulaeha, A.D. (57226286645); Zakiyah, Alfida (57226293808); Aini, Noor (57226289464); An
57212146678; 57226284594; 57226291299; 57204720098; 57186671400; 57226293430; 57203547382; 57226292972; 57226271886; 57226271456; 57211068324; 57226273639; 57211074403; 57226286645; 57226293808; 57226289464; 57226282534
Case report on adjunct intravenous autologous activated platelet-rich plasma therapy in severely ill COVID-19 patients
2021
Biomedical Research and Therapy
8
10
4614
4619
5
0
Klinik Hayandra, Yayasan Hayandra Peduli, Jl. Kramat VI No. 11, Jakarta, Indonesia; HayandraLab, Yayasan Hayandra Peduli, Jl. Kramat VI No. 11, Jakarta, Indonesia; Faculty of Medicine, Universitas Pembangunan Nasional Veteran, Jakarta, Indonesia; Pusat Kajian Stem Cell, Universitas Pembangunan Nasional Veteran, Jakarta, Indonesia; Koja Regional Public Hospital, Jl. Deli No. 4, Jakarta, Indonesia; Department of Biology, Faculty of Mathematics and Natural Sciences, Mulawarman University, Samarinda, Indonesia; Faculty of Medicine, Universitas Indonesia, Jl. Salemba Raya no. 6, Jakarta, Indonesia
Karina K., Klinik Hayandra, Yayasan Hayandra Peduli, Jl. Kramat VI No. 11, Jakarta, Indonesia, HayandraLab, Yayasan Hayandra Peduli, Jl. Kramat VI No. 11, Jakarta, Indonesia, Faculty of Medicine, Universitas Pembangunan Nasional Veteran, Jakarta, Indonesia, Pusat Kajian Stem Cell, Universitas Pembangunan Nasional Veteran, Jakarta, Indonesia; Christoffel L.M., Koja Regional Public Hospital, Jl. Deli No. 4, Jakarta, Indonesia; Novariani R., Koja Regional Public Hospital, Jl. Deli No. 4, Jakarta, Indonesia; Rosadi I., HayandraLab, Yayasan Hayandra Peduli, Jl. Kramat VI No. 11, Jakarta, Indonesia, Department of Biology, Faculty of Mathematics and Natural Sciences, Mulawarman University, Samarinda, Indonesia; Rosliana I., HayandraLab, Yayasan Hayandra Peduli, Jl. Kramat VI No. 11, Jakarta, Indonesia; Rosidah S., Koja Regional Public Hospital, Jl. Deli No. 4, Jakarta, Indonesia; Sobariah S., HayandraLab, Yayasan Hayandra Peduli, Jl. Kramat VI No. 11, Jakarta, Indonesia; Fatkhurohman N., Koja Regional Public Hospital, Jl. Deli No. 4, Jakarta, Indonesia; Puspitaningrum N., Koja Regional Public Hospital, Jl. Deli No. 4, Jakarta, Indonesia; Hertati Y., Koja Regional Public Hospital, Jl. Deli No. 4, Jakarta, Indonesia; Afini I., HayandraLab, Yayasan Hayandra Peduli, Jl. Kramat VI No. 11, Jakarta, Indonesia; Ernanda D., HayandraLab, Yayasan Hayandra Peduli, Jl. Kramat VI No. 11, Jakarta, Indonesia; Widyastuti T., HayandraLab, Yayasan Hayandra Peduli, Jl. Kramat VI No. 11, Jakarta, Indonesia; Sulaeha A.D., Klinik Hayandra, Yayasan Hayandra Peduli, Jl. Kramat VI No. 11, Jakarta, Indonesia; Zakiyah A., HayandraLab, Yayasan Hayandra Peduli, Jl. Kramat VI No. 11, Jakarta, Indonesia; Aini N., HayandraLab, Yayasan Hayandra Peduli, Jl. Kramat VI No. 11, Jakarta, Indonesia; Andrew H., HayandraLab, Yayasan Hayandra Peduli, Jl. Kramat VI No. 11, Jakarta, Indonesia, Faculty of Medicine, Universitas Indonesia, Jl. Salemba Raya no. 6, Jakarta, Indonesia
In most people, COVID-19 presents as a mild disease. However, in many people, especially those with comorbidities, profound inflammation manifesting as a cytokine storm may lead to acute respiratory distress syndrome and multi-organ failure. This novel study reports two severe COVID-19 patients from Koja Regional Hospital: a male aged 52 and a female aged 65. Both patients had poor prognoses based on prognostic biomarkers, disseminated intravascular coagulation, nosocomial infections, and were reintubated more than once. Both patients were treated with adjunct autologous activated platelet-rich plasma — a safe and promising therapy — and were ultimately discharged. Thus, this study reports the potential of autologous activated platelet-rich plasma as supportive therapy for severe COVID-19 patients. © Biomedpress.
Autologous activated platelet-rich plasma; Coronavirus disease 2019; Disseminated intravascular coagulation; Inflammation; Nosocomial infection
aspartate aminotransferase; C reactive protein; D dimer; dexamethasone; heparin; procalcitonin; remdesivir; sodium; absolute lymphocyte count; activated partial thromboplastin time; adult; adult respiratory distress syndrome; aged; Article; artificial ventilation; case report; centrifugation; clinical article; coronavirus disease 2019; coughing; dyspnea; female; fever; Horowitz index; human; intensive care unit; intubation; Klebsiella pneumoniae; lung infiltrate; lymphocyte count; male; middle aged; neutrophil lymphocyte ratio; oxygen saturation; prothrombin time; Pseudomonas aeruginosa; reverse transcription polymerase chain reaction; Staphylococcus haemolyticus; thrombocyte rich plasma
BiomedPress
21984093
Article
#N/A